Table 5. Case fatality rate according to antibiotic therapy used.
| Guided treatment | Number treated | Deaths at 30 days | % |
|---|---|---|---|
| Meropenem + amikacin | 11 | 2 | 18% |
| Meropenem + colistin | 9 | 2 | 22% |
| Meropenem | 9 | 3 | 25% |
| Ceftazidime-avibactam | 5 | 0 | 0% |
| Colistin | 4 | 4 | 100% |
| Tigecycline + colistin | 3 | 1 | 33% |
| Amikacins + colistin | 2 | 1 | 50% |
| Meropenem + gentamicin | 2 | 0 | 0% |
| Tigecycline + piperacillin/tazobactam + clindamycin | 1 | Unknown | Unknown |
| Meropenem + ceftazidime | 1 | 1 | 100% |
| Amikacin + colistin + ceftazidime-avibactam | 1 | 0 | 0% |
| Ceftazidime-avibactam + linezolid | 1 | 0 | 0% |
| Colistin + ampicillin | 1 | 0 | 0% |
| Colistin + tigecycline | 1 | 0 | 0% |
| Colistin + gentamicin | 1 | 0 | 0% |
| Gentamicin + cefotaxime | 1 | 0 | 0% |
| Ciprofloxacin | 1 | 0 | 0% |
| Unknown | 1 | 0 | 0% |
| Total | 54 | 13 | 24% |